Compare Devon Energy Corp (DVN) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Devon Energy Corp vs State Street SPDR S&P Biotech ETF — how do they compare? Devon Energy Corp trades at $48.31 (market cap $53.81B), while State Street SPDR S&P Biotech ETF trades at $153.99 (market cap $10.11B). The key difference: Devon Energy Corp is far larger — about 5.3× State Street SPDR S&P Biotech ETF's market cap, and Devon Energy Corp pays a 2.62% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Devon Energy Corp for 136 Days and State Street SPDR S&P Biotech ETF for 38 Days on average.
| DVN | XBI | |
|---|---|---|
Market Cap | $53.81B | $10.11B |
Volume | 11,556,740 | 12,903,266 |
Sector | Energy | Broad Market / Factor |
52-Week High | $52.07 | $169.55 |
52-Week Low | $31.74 | $104.99 |
Typical Hold Time | 136 Days | 38 Days |
Enterprise Value | $64.55B | — |
Dividend Yield | 2.62% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Devon Energy (DVN) trades at $48.69, up 1.69% today, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 10.63, net income margin of 16.67%, and positive cash flow trends. Recent news highlights activist investor pressure for strategic alternatives, including a potential sale, amid ongoing M&A interest from firms like BP.
The outlook is positive, driven by valuation discounts, earnings beats, and potential asset sales, but risks include oil price volatility and execution challenges. Analyst consensus is strongly bullish with a $62.53 price target, suggesting significant upside from current levels.
XBI trades at $153.84, up 2.4% today, but technical indicators signal a bearish trend with resistance at $154. The ETF's modified equal-weight structure offers broad biotech exposure, benefiting from M&A activity and positive clinical catalysts, though key financial ratios are unavailable. Recent news highlights sector optimism driven by cancer vaccine breakthroughs and improved capital access.
Outlook is mixed: bullish sentiment from innovation and M&A supports growth potential, but high volatility and expense ratios relative to peers pose risks. Analyst consensus is neutral (100% Hold), suggesting cautious optimism amid technical bearishness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Devon Energy Corp
Devon Energy, based in Oklahoma City, is one of the largest independent exploration and production companies in North America. The firm's asset base is spread throughout onshore North America and includes exposure to the Delaware, STACK, Eagle Ford, Powder River Basin, and Bakken plays. At year-end 2021, Devon's proved reserves totaled 1.6 billion barrels of oil equivalent, and net production that year was 572 thousand boe/d, of which oil and natural gas liquids made up 74% of production, with natural gas accounting for the remainder.
Read more on DVN →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
